BCL2L11 and lip and oral cavity carcinoma: Therefore, it is possible that the antitumor effects of ABT-737 on the oral cancer cells may contribute to Bim regulation both at the transcriptional and/or post-translational levels via suppressing the ERK1/2 signaling pathway.